Compare CWST & IRTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CWST | IRTC |
|---|---|---|
| Founded | 1975 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Environmental Services | Medical/Dental Instruments |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.3B | 5.8B |
| IPO Year | 1997 | 2016 |
| Metric | CWST | IRTC |
|---|---|---|
| Price | $105.86 | $168.29 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 13 |
| Target Price | $119.44 | ★ $217.31 |
| AVG Volume (30 Days) | ★ 1.2M | 627.4K |
| Earning Date | 02-11-2026 | 02-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 102.54 | N/A |
| EPS | ★ 0.24 | N/A |
| Revenue | ★ $1,795,272,000.00 | $702,573,000.00 |
| Revenue This Year | $20.40 | $27.30 |
| Revenue Next Year | $7.63 | $17.01 |
| P/E Ratio | $441.72 | ★ N/A |
| Revenue Growth | 20.54 | ★ 25.45 |
| 52 Week Low | $82.22 | $92.52 |
| 52 Week High | $121.24 | $212.00 |
| Indicator | CWST | IRTC |
|---|---|---|
| Relative Strength Index (RSI) | 68.18 | 44.39 |
| Support Level | $97.94 | $149.85 |
| Resistance Level | $101.20 | $174.36 |
| Average True Range (ATR) | 2.69 | 8.37 |
| MACD | 0.25 | -1.55 |
| Stochastic Oscillator | 99.40 | 43.03 |
Casella Waste Systems Inc is a solid waste removal company, providing resource management services to residential, commercial, municipal, and industrial customers. The company's reportable segments on Geographical basis include Eastern, Western and Mid-Atlantic regions through the Resource solution segment. It generates maximum revenue from the Western region segment. The company's services include Recycling, Collection, Organics, Energy, Landfills, Special Waste as well as Professional Services.
iRhythm Technologies Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.